Close

Dr. Reddys launches Heartburn Drug in the US

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Why FDA 510(k) Clearance and EU CE MDR Certification Should Anchor Your Hearing Aid Sourcing Strategy

Introduction For e-commerce platforms, hospital procurement directors, healthcare supply chain...

Gilead Sciences Inaugurates Advanced Research Centre in California

Gilead Sciences has expanded its R&D infrastructure with a new 182,000-square-foot facility in Foster City dedicated to inflammation, oncology, and data science.

Research Peptide Quality: What Laboratories Need to Know

Research Peptides in Modern Drug Discovery: Quality, Purity, and...
- Advertisement -

Dr. Reddy’s has launched over-the-counter Heartburn drug called Lansoprazole delayed-release capsules in the US Market. The company has come up with these capsules in the strength of 15 mg. as approved by the US FDA. These capsules can be used to treat frequent heartburn that occurs two or three days in a week.

As per the statement released by the company, they are pleased to continue to expand their antacids and PPI portfolio for the customers. The company’s product is equivalent to Takeda Pharmaceuticals North America Inc’s Prevacid 24HR capsules.

 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Why FDA 510(k) Clearance and EU CE MDR Certification Should Anchor Your Hearing Aid Sourcing Strategy

Introduction For e-commerce platforms, hospital procurement directors, healthcare supply chain...

Gilead Sciences Inaugurates Advanced Research Centre in California

Gilead Sciences has expanded its R&D infrastructure with a new 182,000-square-foot facility in Foster City dedicated to inflammation, oncology, and data science.

Research Peptide Quality: What Laboratories Need to Know

Research Peptides in Modern Drug Discovery: Quality, Purity, and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »